Summary
- Current Price
- As of today, CTOR price is $0.69, with unknown change on
- Current Price All-Time High
- CTOR price is currently -98.60% below its historical high of $49.00 set on
- Market Cap
- CTOR current market cap is $61M, up +23.91% over the past 365 days
- PE Ratio
- CTOR PE ratio is unknown
- Revenue
- CTOR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for CTOR has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Citius Oncology, Inc. |
| Ticker | NASDAQ: CTOR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | citiusonc.com |
| Employees | - |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.69 | ||
| Price, 1D Change | - | |
| $61M | ||
| - | ||
| - | ||
| 0.95 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.34 | ||
| EPS, 1Y Change | -8.75% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | TENK | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.34 | ||
| EPS Estimate | N/A | -$0.19 |
| EPS Est. Change | N/A | +43.79% |
| $0.00 | ||
| Revenue Estimate | N/A | $38.87M |
| Revenue Est. Change | N/A | - |
| $0.69 | ||
| Price Target | - | $6.00 |
| Price Tgt. Change | - | +773.36% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.33 | -$0.34 | -2.42% | |
| -$0.19 | N/A | +43.79% | |
| $0.39 | N/A | +215.38% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $38.87M | N/A | - | |
| $118.95M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +0.44% | ||
| -93.36% | ||
| +23.91% | ||
| -34.98% | ||
| 0.00% | ||
| 0.00% | ||
| -8.75% | ||
| -342.99% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.69 | ||
| $1.59 | ||
| SMA 200 vs Price | +131.59% | |
| $0.96 | ||
| SMA 50 vs Price | +39.13% | |
| 0.95 | ||
| $0.08 | ||
| 41.60 | ||
| 157.61% | ||
| 131.33% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.34 | ||
| $0.00 | ||
| - | ||
| -$23.52M | ||
| - | ||
| -$24.76M | ||
| - | ||
| -$23.52M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.08 | ||
| 0.56 | ||
| 0.11 | ||
| - | ||
| - | ||
| -1.27 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 15.38 | ||
| 1.04 | ||
| -2.55 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $44.87M | ||
| $3.92M | ||
| $100.94M | ||
| $27.54M | ||
| $56.08M | ||
| $49.49M | ||
| $3.80M | ||
| $0.00 | ||
| $13.23M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $24.76M | ||
| $23.52M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $1.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$5.49M | ||
| -$5.75M | ||
| $15.17M | ||
| $0.00 | ||
| -$5.49M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Maxim Group | ||
| EF Hutton | → |
Analyst sentiment
Institutional ownership
Screeners with CTOR
FAQ
What is the ticker symbol for Citius Oncology, Inc.?
The ticker symbol for Citius Oncology, Inc. is NASDAQ:CTOR
Does Citius Oncology, Inc. pay dividends?
No, Citius Oncology, Inc. does not pay dividends
What sector is Citius Oncology, Inc. in?
Citius Oncology, Inc. is in the Healthcare sector
What industry is Citius Oncology, Inc. in?
Citius Oncology, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Citius Oncology, Inc. based in?
Citius Oncology, Inc. is headquartered in United States
When did Citius Oncology, Inc. go public?
Citius Oncology, Inc. initial public offering (IPO) was on December 8, 2022
Is Citius Oncology, Inc. in the S&P 500?
No, Citius Oncology, Inc. is not included in the S&P 500 index
Is Citius Oncology, Inc. in the NASDAQ 100?
No, Citius Oncology, Inc. is not included in the NASDAQ 100 index
Is Citius Oncology, Inc. in the Dow Jones?
No, Citius Oncology, Inc. is not included in the Dow Jones index
When was Citius Oncology, Inc. last earnings report?
Citius Oncology, Inc.'s most recent earnings report was on December 26, 2025
When does Citius Oncology, Inc. report earnings?
The date for Citius Oncology, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CTOR Official Website www.citiusonc.com/overview/default.aspx
- CTOR Profile on Yahoo Finance finance.yahoo.com/quote/CTOR
- CTOR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ctor